Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|
Net Income | $5,669.0K | ($38.1M) | ($307.2M) | ($215.6M) | ($186.3M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, LifeStance Health Group, Inc.'s last 12-month Net Income is ($95.3M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, LifeStance Health Group, Inc.'s Net Income growth was (49.3%). The average annual Net Income growth rates for LifeStance Health Group, Inc. have been 63.5% over the past three years, N/A over the past five years.
Over the last year, LifeStance Health Group, Inc.'s Net Income growth was (49.3%), which is lower than industry growth of 9.6%. It indicates that LifeStance Health Group, Inc.'s Net Income growth is Bad.